Galectin Therapeutics Inc. Share Price
GALTGalectin Therapeutics Inc. Stock Performance
Open $2.35 | Prev. Close $2.42 | Circuit Range N/A |
Day Range $2.33 - $2.50 | Year Range $1.30 - $7.13 | Volume 19,393 |
Average Traded $2.38 |
Galectin Therapeutics Inc. Share Price Chart
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Galectin Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $2.35 | $2.39 | +0.00% |
10-Jun-26 | $2.35 | $2.39 | -1.44% |
09-Jun-26 | $2.41 | $2.42 | +1.89% |
08-Jun-26 | $2.35 | $2.38 | +2.37% |
05-Jun-26 | $2.36 | $2.33 | -1.90% |
04-Jun-26 | $2.38 | $2.37 | +1.07% |
03-Jun-26 | $2.39 | $2.35 | -3.50% |
FAQs on Galectin Therapeutics Inc. Share Price
Can I buy Galectin Therapeutics Inc. shares in India?
What is the share price of Galectin Therapeutics Inc.?
What is the 5 year returns of Galectin Therapeutics Inc.?
What are the high & low stock price of Galectin Therapeutics Inc. today?
What is the 52-week high and low of Galectin Therapeutics Inc. stock?